These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 406271)

  • 21. Gonadotropinic reserve in women affected by hyperprolactinemic amenorrhea.
    Abate F; Oliva A; Baviera G; Martino P; Cannavò A; Leonardi R
    Clin Exp Obstet Gynecol; 1980; 7(2):126-30. PubMed ID: 7018740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal.
    Tucker HS; Grubb SR; Wigand JP; Taylon A; Lankford HV; Blackard WG; Becker DP
    Ann Intern Med; 1981 Mar; 94(3):302-7. PubMed ID: 6784626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of a silent pituitary somatotroph adenoma in a patient with amenorrhea and/or galactorrhea: paradoxical response of GH in TRH or GnRH provocation test.
    Matsuno A; Ogino Y; Itoh J; Osamura RY; Nagashima T
    Endocr J; 2000 Mar; 47 Suppl():S105-9. PubMed ID: 10890196
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 25. alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine.
    Klibanski A; Beitins IZ; Zervas NT; McArthur JW; Ridgway EC
    J Clin Endocrinol Metab; 1983 Apr; 56(4):774-80. PubMed ID: 6187760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical use of metoclopramide test in the diagnosis of women with hyperprolactinemia.
    Vázquez-Matute L; Canales ES; Alger M; Zárate A
    Horm Res; 1979; 10(4):207-12. PubMed ID: 571836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperprolactinemic disorders.
    Molitch ME; Reichlin S
    Dis Mon; 1982 Jun; 28(9):1-58. PubMed ID: 6123422
    [No Abstract]   [Full Text] [Related]  

  • 28. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamus-pituitary function in amenorrhea-galactorrhea syndrome.
    Delitala G; Masala A; Alagna S; Devilla L
    Panminerva Med; 1978; 20(2):89-96. PubMed ID: 212704
    [No Abstract]   [Full Text] [Related]  

  • 30. Physiologic and pathologic profiles of circulating human prolactin.
    Jaffe RB; Yuen BH; Keye WR; Midgley AR
    Am J Obstet Gynecol; 1973 Nov; 117(6):757-73. PubMed ID: 4200810
    [No Abstract]   [Full Text] [Related]  

  • 31. The post-pill secondary amenorrhea: etiology and treatment.
    Del Olmo J; De Pablos I; Guadalix FJ; Botella-Llusia J
    Acta Eur Fertil; 1981 Jun; 12(2):133-9. PubMed ID: 6794287
    [No Abstract]   [Full Text] [Related]  

  • 32. Luteinizing hormone- and alpha-subunit-secreting pituitary tumor: positive feedback of estrogen.
    Peterson RE; Kourides IA; Horwith M; Vaughan ED; Saxena BB; Fraser RA
    J Clin Endocrinol Metab; 1981 Apr; 52(4):692-8. PubMed ID: 6782117
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
    Rjosk HK; Werder K; Fahlbusch R
    Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):575-87. PubMed ID: 986336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin and gonadal function.
    Besser GM; Thorner MO
    Pathol Biol (Paris); 1975 Dec; 23(10):779-82. PubMed ID: 817251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal pituitary function and reserve after selective transsphenoidal removal of a thyrotropin-producing pituitary adenoma.
    Barbarino A; De Marinis L; Anile C; Maira G
    Metabolism; 1980 Aug; 29(8):739-44. PubMed ID: 6772922
    [No Abstract]   [Full Text] [Related]  

  • 36. Normal pregnancies after treatment of hyperprolactinemia with bromoergocryptine, despite suspected pituitary tumors.
    Mornex R; Orgiazzi J; Hugues B; Gagnaire JC; Claustrat B
    J Clin Endocrinol Metab; 1978 Aug; 47(2):290-5. PubMed ID: 400717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial or complete regression of hyperprolactinemic amenorrhea-galactorrhea syndrome after bromocriptine-induced pregnancy.
    Molinatti GM; Campagnoli C; Belforte L; Massara F; Peris C; Pinna N
    Panminerva Med; 1980; 22(3):125-30. PubMed ID: 7208090
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of L-DOPA on serum prolactin in cases of galactorrhea-amenorrhea caused by a pituitary adenoma].
    Barreca T; Masturzo P; Rolandi E; Polleri A
    Boll Soc Ital Biol Sper; 1974 Nov; 50(21):1857-61. PubMed ID: 4477960
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute visual loss during pregnancy after bromocriptine-induced ovulation. The elusive tumor.
    Burry KA; Schiller HS; Mills R; Harris B; Heinrichs L
    Obstet Gynecol; 1978 Jul; 52(1 Suppl):19S-22S. PubMed ID: 683637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
    Yarkoni S; Spitz IM; Ben-David M; Polishuk WZ
    Acta Eur Fertil; 1978 Dec; 9(4):185-8. PubMed ID: 573042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.